Reference: FOI 25926 BAN 11E
Subject: Asthma and COPD Inhalers
I can confirm that the CCG does hold the information requested; please see responses below:
QUESTION
RESPONSE
I would like to request the information about the following points around the CCG's decisions with patient care and its structure.
BaNES CCG can confirm that it does hold this information, but are
exempting it unde
r Section 21 Freedom of Information Act 2000 as it
is reasonably accessible by other means. This is an absolute
• What criteria does the CCG use to select which inhalers
exemption.
should be prescribed for Asthma and COPD?
I have provided you with a link to the website which will provide you
with this information:
https://www.bcapformulary.nhs.uk/3-respiratory-system
• How does the CCG compare the cost-effectiveness , efficacy, BaNES CCG can confirm that it does hold this information, but are
safety and patient usability of different inhalers when selecting exempting it unde
r Section 21 Freedom of Information Act 2000 as it
which COPD and Asthma inhalers should be included on its
is reasonably accessible by other means. This is an absolute
local guidance?
exemption.
1
I have provided you with a link to the website which will provide you
with this information:
https://www.bcapformulary.nhs.uk/prescribing-guidelines
• Over the past three years, has the CCG introduced a planned
programme of care which resulted in the medicines
We have encouraged our practice pharmacists and team to
optimisation team, contractors or GP practices proactively
implement some switches in line with the BCAP formulary
reviewing patients and aligning their COPD and/or Asthma
inhalers to alternative options?
BaNES CCG can confirm that it does hold this information, but are
exempting it unde
r Section 21 Freedom of Information Act 2000 as it
• Please list the alternative asthma and COPD inhalers that
is reasonably accessible by other means. This is an absolute
were introduced by the CCGs medicines optimisation team,
exemption.
contractors or GP practices during any planned programme of
care that proactively reviewed the use of asthma and/or COPD
I have provided you with a link to the website which will provide you
inhalers over the past 3 years .
with this information:
https://www.bcapformulary.nhs.uk/3-respiratory-system - we would
have only encouraged switching in line with formulary
• Over the past three years, has the CCG used a QIPP scheme
No we have asked practices to identify their own savings plans each
year, of which may have chosen respiratory products.
to introduce a planned programme of care which resulted in
We have not utilised our central savings team to focus on
the medicines optimisation team, contractors or GP practices
respiratory – we may do that in 2018/19
proactively reviewing patients and aligning their COPD and/or
2
Asthma inhalers to alternative options?
BaNES CCG can confirm that it does hold this information, but are
exempting it unde
r Section 21 Freedom of Information Act 2000 as it
• Please list the alternative asthma and COPD inhalers that
is reasonably accessible by other means. This is an absolute
were introduced by the CCGs medicines optimisation team,
exemption.
contractors or GP practices when using a QIPP scheme to
introduce a planned programme of care that proactively
I have provided you with a link to the website which will provide you
reviewed the use of asthma and/ or COPD inhalers over the
with this information:
past 3 years?
https://www.bcapformulary.nhs.uk/3-respiratory-system - we would
have only encouraged switching in line with formulary
The information provided in this response is accurate as of 25 April 2018, and has been authorised for release by Julie-Anne
Wales, Head of Corporate Governance and Planning for NHS BaNES CCG.
3